| Model Number |
560BCS1 |
| Medical Device Problem Code |
Battery Problem (2885)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
10/30/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Device evaluation summary: the reported issue that batteries died too quicly during patient transport was verified during service.The issue was resolved by re placing the battery,12v,6.5 ah,certified*2.Preventive maintenance was performed per specifications.Note: the instrument was serviced in the facility by a field service technician.The instrument was not returned to a medtronic facility for service/analysis.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that during use of a bio-console 560 instrument, it was reported that batteries died too quickly during patient transport.The instrument was replaced to complete the procedure.There was no adverse patient effect associated with this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic received additional information that the lot number of the battery removed from the instrument was 11953255.The batteries were installed four years ago.The battery power did not long last and the customer did not measure the exact time.The displayed battery charge indicator and battery alarms were working appropriately.A hand crank was used to maintain flow to the patient.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|